Market Cap: $1.64B
NI
Novavax, Inc.
NVAX
NASDAQ (NASDAQ Global Select)USD
Market Cap: $1.64B
Novavax Strengthens R&D Leadership with New Appointment Novavax, Inc. (Nasdaq: NVAX) announces a significant leadership change with the appointment of Dr. Robert Walker, MD, as Executive Vice Presiden…
Novavax's Financial Performance Drives Investor Interest Amid Market Volatility Novavax Inc. showcases its resilience through a detailed revelation of its financial performance for the fourth quarter…
Novavax Reports Robust Q4 Earnings, Strengthening Biopharmaceutical Position On February 26, 2026, Novavax (NASDAQ: NVAX) announces its Q4 earnings results, highlighting a strong performance that soli…
Novavax Prepares for Earnings Release Amidst Health Sector Growth As Novavax gears up to release its earnings report, attention turns to the company’s position within the rapidly evolving health secto…
Novavax Faces Growing Competition in Vaccine Market As the global demand for COVID-19 vaccines stabilizes, Novavax finds itself in a pivotal moment, focusing on maintaining its relevance and expanding…
Novavax and Pfizer Forge Strategic Partnership to Enhance Vaccine Development Novavax, Inc. has entered into a significant licensing agreement with Pfizer that permits the pharmaceutical giant to util…
Novavax’s Strategic Focus Amidst Market Noise Novavax continues to carve out a vital role in the biotechnology sector, especially in the development of vaccines. The company is currently navigating a…
Novavax’s Path to Innovation Amidst Market Noise Novavax continues to carve a unique position within the biotechnology sector, focusing on the development of vaccines for infectious diseases. As the c…
Novavax Showcases Commitment to Global Health at Jefferies London Healthcare Conference Novavax, Inc. (Nasdaq: NVAX) prepares to engage with stakeholders at the upcoming Jefferies London Healthcare Co…
Novavax Showcases Commitment to Global Health at Jefferies London Healthcare Conference Novavax, Inc. (Nasdaq: NVAX) prepares to participate in the upcoming Jefferies London Healthcare Conference on N…
Novavax Faces Market Challenges Amid Economic Uncertainty In the wake of recent market fluctuations, Novavax, a key player in the biotechnology sector, is navigating a landscape marked by heightened i…
Novavax Receives Positive Rating Amidst Competitive Landscape in Vaccine Development Novavax, a biotech company specializing in vaccine development, garners attention with its recent initiation of cov…
Novavax Streamlines Operations with Strategic Facility Consolidation Novavax, Inc. is taking a decisive step towards operational efficiency by consolidating its Maryland facilities. The company announ…
Novavax Consolidates Operations to Enhance R&D Focus Novavax, Inc., a biotech firm based in Gaithersburg, Maryland, announces a pivotal step towards streamlining its operations by consolidating its fa…
Novavax Faces Pressure to Reassess Strategic Direction Amid Distribution Challenges Novavax Inc. is currently at a critical crossroads as it grapples with significant challenges in the distribution of…
Novavax Faces Pressure for Strategic Reassessment Amid Vaccine Distribution Challenges Novavax Inc. grapples with significant challenges in the commercialization of its COVID-19 vaccine, prompting Sha…
Impeachment Push Signals Turbulence in Health Governance Rep. Haley Stevens (D-Mich.) announces her intention to introduce articles of impeachment against Health and Human Services Secretary Robert F.…
Vaccination Controversy: The Impact of Trump's Advice on Public Health Amid ongoing discussions about childhood immunizations, President Donald Trump stirs controversy with his recent comments suggest…
Urgent Call for Timely Vaccinations Amid CDC Vaccine Controversy In a recent development that raises alarms in the public health sector, Senator Elizabeth Warren (D-Mass.) has vocally criticized the C…
### Enhancing Vaccine Safety Insights for Expectant Mothers U.S. Health and Human Services Secretary Robert F. Kennedy Jr. leads a renewed initiative focused on the safety of COVID-19 vaccines, partic…
Enhancing Transparency on COVID-19 Vaccines for Pregnant Women: A Critical Initiative U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and his top health officials are intensifying effor…
Navigating Vaccine Policy: Challenges Ahead for HHS Secretary Kennedy In a recent Senate hearing, Secretary for Health and Human Services Robert F. Kennedy Jr. faces substantial bipartisan criticism o…
Vaccine Mandates and Public Health: A Divided Approach in the U.S. Florida's recent decision to eliminate all statewide vaccine mandates, including those crucial for school attendance, underscores a s…
### Diverging Public Health Strategies: Florida's Vaccine Mandate Repeal Florida's recent decision to eliminate all statewide vaccine mandates, including those required for school attendance, marks a…
### Novavax Navigates New COVID-19 Vaccine Landscape Amid Regulatory Changes Novavax faces a shifting landscape in the COVID-19 vaccine market as the U.S. Food and Drug Administration (FDA) recently a…